University of Novi Sad Faculty of Technical Sciences

Sorrento Releases Positive Topline Results from the Phase I Study Completed in Australia and Preliminary Results from a Phase Ib Study in China with STI-1558, an Oral M(pro) Inhibitor as a Standalone Treatment for COVID-19 without the Need for Ritonavir B

Retrieved on: 
Tuesday, November 29, 2022
SAN, Wireless ambulatory ECG, CYP3A4, Bilirubin, Therapy, Osteoarthritis, Security (finance), BID, Sciatica, Severe acute respiratory syndrome coronavirus 2, NMPA, Cathepsin L, Pharmacokinetics, TRPV1, PK, User experience, Pain, Patient, Risk, Trial of the century, University of Novi Sad Faculty of Technical Sciences, FDA, Autoimmune disease, SAD, RNA, Phase, Mpro, Toxicity, Postherpetic neuralgia, Annual report, Death, AES, Liver, AUC, Headache, Antibody, RTX, Viral load, Vital signs, PHN, AE, PCR, Cancer, Ritonavir, Vaccine, Generic drug, Copper, Pharmaceutical industry, COVID-19, Safety, Tolerability

There were no severe or serious AEs, no premature discontinuation of STI-1558 due to an AE, and no deaths.

Key Points: 
  • There were no severe or serious AEs, no premature discontinuation of STI-1558 due to an AE, and no deaths.
  • Even the lowest dose produced trough levels significantly above the EC90 value for viral inhibition of STI-1558.
  • A similar Phase I/Ib SAD/MAD study has been fully enrolled in China in both healthy subjects and patients infected with SARS-CoV-2.
  • The liver enzyme elevations occurred late ( 5 days) in study treatment and resolved without the need for any treatment.

Novo Nordisk Foundation announces support for new open collaborative platform to accelerate the development of plant-based foods

Retrieved on: 
Thursday, November 10, 2022
Wageningen University & Research, University, Intellectual property, Technical University of Denmark Department of Mathematics, University of Copenhagen Center for Planetary Research, Aarhus University, Institute of technology, Natural science, Knowledge, Research, Foundation, TRL, Food industry, Technology, Faculty, Novo Nordisk Foundation, Solution, University of Novi Sad Faculty of Technical Sciences, Senior, Taste, Industry, Food, Pharmaceutical industry, Aquaculture, Fertilizer, Creative industries, Science, Biotechnology

HELLERUP, Denmark, Nov. 10, 2022 /PRNewswire/ -- A new collaborative platform, Plant2Food, aims to accelerate the development of plant-based foods.

Key Points: 
  • HELLERUP, Denmark, Nov. 10, 2022 /PRNewswire/ -- A new collaborative platform, Plant2Food, aims to accelerate the development of plant-based foods.
  • The Novo Nordisk Foundation is supporting the platform with up to 27 million over the next five years.
  • The aim is to accelerate the overall development of new plant-based foods and to optimise collaboration across the various sectors within plant and food science.
  • Plant2Food will be an Open Innovation in Science platform focusing on open research collaboration.

Novo Nordisk Foundation announces support for new open collaborative platform to accelerate the development of plant-based foods

Retrieved on: 
Thursday, November 10, 2022
Wageningen University & Research, University, Intellectual property, Technical University of Denmark Department of Mathematics, University of Copenhagen Center for Planetary Research, Aarhus University, Institute of technology, Natural science, Knowledge, Research, Foundation, TRL, Food industry, Technology, Faculty, Novo Nordisk Foundation, Solution, University of Novi Sad Faculty of Technical Sciences, Senior, Taste, Industry, Food, Pharmaceutical industry, Aquaculture, Fertilizer, Creative industries, Science, Biotechnology

HELLERUP, Denmark, Nov. 10, 2022 /PRNewswire/ -- A new collaborative platform, Plant2Food, aims to accelerate the development of plant-based foods.

Key Points: 
  • HELLERUP, Denmark, Nov. 10, 2022 /PRNewswire/ -- A new collaborative platform, Plant2Food, aims to accelerate the development of plant-based foods.
  • The Novo Nordisk Foundation is supporting the platform with up to 27 million over the next five years.
  • The aim is to accelerate the overall development of new plant-based foods and to optimise collaboration across the various sectors within plant and food science.
  • Plant2Food will be an Open Innovation in Science platform focusing on open research collaboration.

Novo Nordisk Foundation establishes fellowships with four top international universities

Retrieved on: 
Tuesday, October 11, 2022
James H. Clark Center, Weizmann Institute of Science, Harkness Fellowship, Novo Nordisk Foundation, Family, Foundation, Stanford University, Temasek Foundation, Research, Senior, Knowledge, University, Doctor of Philosophy, Health, Internationalization, Intention, MIT, Program, Faculty, Association, Creativity, University of Oxford, Interdisciplinarity, Nature, University of Novi Sad Faculty of Technical Sciences, Solution, Fellow, Renewable energy, Creative industries, Pharmaceutical industry, Veterinary medicine, Innovation

The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.

Key Points: 
  • The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.
  • Lene Oddershede, Senior Vice President, Natural & Technical Sciences, Novo Nordisk Foundation, says: "At the Novo Nordisk Foundation, we want to promote quality research and innovation at the highest international level and to bring novel research expertise to Denmark.
  • Read more about the application process here: Fellowships at MIT , Fellowships at Stanford Bio-X , Fellowships at University of Oxford and Fellowships at Weizmann Institute of Science .
  • Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives.

Novo Nordisk Foundation establishes fellowships with four top international universities

Retrieved on: 
Tuesday, October 11, 2022
James H. Clark Center, Weizmann Institute of Science, Harkness Fellowship, Novo Nordisk Foundation, Family, Foundation, Stanford University, Temasek Foundation, Research, Senior, Knowledge, University, Doctor of Philosophy, Health, Internationalization, Intention, MIT, Program, Faculty, Association, Creativity, University of Oxford, Interdisciplinarity, Nature, University of Novi Sad Faculty of Technical Sciences, Solution, Fellow, Renewable energy, Creative industries, Pharmaceutical industry, Veterinary medicine, Innovation

The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.

Key Points: 
  • The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.
  • Lene Oddershede, Senior Vice President, Natural & Technical Sciences, Novo Nordisk Foundation, says: "At the Novo Nordisk Foundation, we want to promote quality research and innovation at the highest international level and to bring novel research expertise to Denmark.
  • Read more about the application process here: Fellowships at MIT , Fellowships at Stanford Bio-X , Fellowships at University of Oxford and Fellowships at Weizmann Institute of Science .
  • Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives.

Novo Nordisk Foundation establishes fellowships with four top international universities

Retrieved on: 
Monday, October 10, 2022
James H. Clark Center, Weizmann Institute of Science, Harkness Fellowship, Novo Nordisk Foundation, Family, Foundation, Stanford University, Temasek Foundation, Research, Senior, Knowledge, University, Doctor of Philosophy, Health, Internationalization, Intention, MIT, Program, Faculty, Association, Creativity, University of Oxford, Interdisciplinarity, Nature, University of Novi Sad Faculty of Technical Sciences, Solution, Fellow, Renewable energy, Creative industries, Pharmaceutical industry, Veterinary medicine, Innovation

The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.

Key Points: 
  • The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.
  • Lene Oddershede, Senior Vice President, Natural & Technical Sciences, Novo Nordisk Foundation, says: "At the Novo Nordisk Foundation, we want to promote quality research and innovation at the highest international level and to bring novel research expertise to Denmark.
  • Read more about the application process here: Fellowships at MIT , Fellowships at Stanford Bio-X , Fellowships at University of Oxford and Fellowships at Weizmann Institute of Science .
  • Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives.

Novo Nordisk Foundation establishes fellowships with four top international universities

Retrieved on: 
Monday, October 10, 2022
James H. Clark Center, Weizmann Institute of Science, Harkness Fellowship, Novo Nordisk Foundation, Family, Foundation, Stanford University, Temasek Foundation, Research, Senior, Knowledge, University, Doctor of Philosophy, Health, Internationalization, Intention, MIT, Program, Faculty, Association, Creativity, University of Oxford, Interdisciplinarity, Nature, University of Novi Sad Faculty of Technical Sciences, Solution, Fellow, Renewable energy, Creative industries, Pharmaceutical industry, Veterinary medicine, Innovation

The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.

Key Points: 
  • The Novo Nordisk Foundation wants to give researchers in Denmark the opportunity to seek inspiration and acquire new knowledge and skills by supporting their research stays at top international research institutions.
  • Lene Oddershede, Senior Vice President, Natural & Technical Sciences, Novo Nordisk Foundation, says: "At the Novo Nordisk Foundation, we want to promote quality research and innovation at the highest international level and to bring novel research expertise to Denmark.
  • Read more about the application process here: Fellowships at MIT , Fellowships at Stanford Bio-X , Fellowships at University of Oxford and Fellowships at Weizmann Institute of Science .
  • Established in Denmark in 1924, the Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives.

Novo Nordisk Foundation launches major investment to develop the first quantum computer dedicated to life sciences research and the green transition

Retrieved on: 
Wednesday, September 21, 2022
People, University, IT University of Copenhagen, QPU, Health, Novo Nordisk Foundation, Delft University of Technology, Algorithm, Niels Bohr Institute, Computer, Nature, Senior, Climate change, Noise, Diabetes, CEO, Quantum, Technology, Program, University of Toronto, Solution, Institute of technology, Technical University of Denmark, Foundation, Massachusetts Institute of Technology School of Science, University of Copenhagen, Ecosystem, University of Novi Sad Faculty of Technical Sciences, Research, Medicine, DKK, Hospital, Drug discovery, Genome, Renewable energy, Microscope, Pharmaceutical industry, Video game, Industrial design, Creative industries, Computer data storage

The ambitious Novo Nordisk Foundation Quantum Computing Programme launched in collaboration with theUniversity of Copenhagen includes world-leading researchers in quantum computing from Denmark, Canada, The Netherlands and the USA.

Key Points: 
  • The ambitious Novo Nordisk Foundation Quantum Computing Programme launched in collaboration with theUniversity of Copenhagen includes world-leading researchers in quantum computing from Denmark, Canada, The Netherlands and the USA.
  • Quantum computing offers enormous potential but challenges persist in developing a fully scaled, fault-tolerant, generally applicable quantum computer.
  • Part of the grant for the Novo Nordisk Foundation Quantum Computing Programme is earmarked for establishing Quantum Foundry P/S, a partner company.
  • The mission is to develop and build quantum hardware and algorithms for a quantum computer that can solve important problems in the life sciences.

Novo Nordisk Foundation launches major investment to develop the first quantum computer dedicated to life sciences research and the green transition

Retrieved on: 
Wednesday, September 21, 2022
People, University, IT University of Copenhagen, QPU, Health, Novo Nordisk Foundation, Delft University of Technology, Algorithm, Niels Bohr Institute, Computer, Nature, Senior, Climate change, Noise, Diabetes, CEO, Quantum, Technology, Program, University of Toronto, Solution, Institute of technology, Technical University of Denmark, Foundation, Massachusetts Institute of Technology School of Science, University of Copenhagen, Ecosystem, University of Novi Sad Faculty of Technical Sciences, Research, Medicine, DKK, Hospital, Drug discovery, Genome, Renewable energy, Microscope, Pharmaceutical industry, Video game, Industrial design, Creative industries, Computer data storage

The ambitious Novo Nordisk Foundation Quantum Computing Programme launched in collaboration with theUniversity of Copenhagen includes world-leading researchers in quantum computing from Denmark, Canada, The Netherlands and the USA.

Key Points: 
  • The ambitious Novo Nordisk Foundation Quantum Computing Programme launched in collaboration with theUniversity of Copenhagen includes world-leading researchers in quantum computing from Denmark, Canada, The Netherlands and the USA.
  • Quantum computing offers enormous potential but challenges persist in developing a fully scaled, fault-tolerant, generally applicable quantum computer.
  • Part of the grant for the Novo Nordisk Foundation Quantum Computing Programme is earmarked for establishing Quantum Foundry P/S, a partner company.
  • The mission is to develop and build quantum hardware and algorithms for a quantum computer that can solve important problems in the life sciences.

Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head

Retrieved on: 
Tuesday, August 23, 2022
Alexion, Schizophrenia, MDR, Semmelweis University, COVID-19, The Company, University, XDR, Ophthalmology, Business administration, Research, Central nervous system, Therapy, Rice University, Master of Business Administration, Time, Lists of diseases, Infection, MIT, SVP, CMC, School, Multimedia, Hepatitis B, Alexander, HIV, Health, Company, FDA, Doctor of Philosophy, Biotechnology, Stanford University, Chemical engineering, Merck, University of Novi Sad Faculty of Technical Sciences, Sanofi, Growth, Master of Science, CNS, Anxiety, Temple University School of Medicine, Otsuka Pharmaceutical, Patient, Pharmaceutical industry, Medicine, Medicine, Brexpiprazole, Operation

DURHAM, N.C. and BEIJING, Aug. 22, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the appointments of Eleanor (Ellee) de Groot, Ph.D., as Chief Technology Officer and Aleksandar Skuban, M.D., as Central Nervous System (CNS) Diseases Therapy Area Head.

Key Points: 
  • DURHAM, N.C. and BEIJING, Aug. 22, 2022 /PRNewswire/ -- Brii Biosciences Limited("Brii Bio" or the "Company", stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, today announced the appointments of Eleanor (Ellee) de Groot, Ph.D., as Chief Technology Officer and Aleksandar Skuban, M.D., as Central Nervous System (CNS) Diseases Therapy Area Head.
  • "Ellee and Aleksandar are both seasoned biotech leaders with impressive credentials and an entrepreneurial history of leading medicine development and manufacturing initiatives within their functional areas.
  • Prior to that, he served as an Executive Medical Director leading clinical development within Alexion's emerging ophthalmology therapeutic area.
  • "I am inspired by the meaningful patient-centric approach that Brii Biohas cultivated in the earliest stages of clinical planning.